Clifford Chance offers a broad service offering which covers the full gamut of IP issues within the life sciences sector, including preliminary injunction applications and SPC-related mandates. Practice co-lead Miquel Montañá, who is praised by clients for his ‘curious legal mind’ and ‘unmatched attention to detail’, is noted for his longstanding expertise in patent litigation within the life sciences sector, while fellow co-head Josep Montefusco is a key contact for unfair competition and advertising issues. Also jointly leading the team, Guillermo Guardia stands out for his experience in M&A and joint ventures, and Carme Briera often assists with public law issues within the health sector. Adrián Crespo regularly acts for pharma and biotech clients in major patent validity, revocation, and infringement disputes.

The ‘amazing’ Jordi Faus and Xavier Moliner jointly lead Faus Moliner‘s team, which handles a varied workload of pricing, data and market exclusivity, and clinical trial agreements. Faus utilises his longstanding expertise to handle the full spectrum of pharma regulatory issues, in addition to assisting with the financing of medicinal products and corporate transactions. Moliner specialises in product liability cases and public procurement work. Lluís Alcover is particularly adept at handling market access matters and remains a key contact for clients seeking assistance with having products added to the reimbursement list. Juan Martínez is a key figure within the team who is well equipped to handle product liability litigation and contractual disputes.

With pricing and reimbursement, manufacturing agreements, marketing authorisations forming a key part of Uría Menéndez‘s caseload, the firm is also noted for advising on M&A and the establishment of laboratories. Following the retirement of Teresa Paz-Ares, Beatriz Cocina, Montiano Monteagudo, and Ingrid Pi assumed leadership of the practice. In Madrid, Cocina is an expert in supply systems and collaboration agreements within the healthcare industry. In the Barcelona office, Monteagudo often represents pharma laboratories and corporations in trade mark proceedings and the protection of trade secrets, while Pi is a key contact for patent nullity and infringement proceedings, in addition to interim injunctions. Francisco Javier García assists with unfair competition issues and data privacy work in this space.

Jointly led by Barcelona-based Montserrat Llopart and Cecilia Pastor in Madrid, the team of ‘great experts’ at Baker McKenzie utilises its vast international network to assist with M&A, spin-offs, and pharmacovigilance work. Regulatory expert Llopart is recommended for her wealth of experience in pricing and reimbursement work; her expertise also extends to distribution, licensing, and clinical trial agreements. Pastor specialises in corporate restructuring and transactional mandates within the healthcare and pharma industries. Ester Navas advises on the full range of regulatory issues surrounding the advertising and price discounting of medicinal products and medical devices.

Bird & Bird handles the full range of employment and corporate mandates, in addition to acting in patent infringement and unfair competition proceedings. Coral Yáñez is a regulatory expert who often acts in judicial reviews. Manuel Lobato is a key name for patent and SPC litigation, while seasoned IP litigator José Miguel Lissén focuses on FRAND litigation. Lourdes Ayala has a great deal of expertise in financing issues and M&A, and Miguel Pastur routinely handles employment matters within the healthcare and life sciences spaces.

The versatile team at Cuatrecasas is well equipped to assist with both contentious and non-contentious public procurement mandates, and claims concerning allegations of anti-competitive behaviour. Practice head Elena Cuatrecasas is particularly adept at advising on M&A across the biotech and pharma sectors. Jorge Robles is active within the medical device field, often handling regulatory disputes, while Ariadna Casanueva focuses on healthcare compliance and corporate work.

Noted for its strength in market access issues and public law litigation, Eversheds Sutherland acts for a diverse client roster of major, global pharma and biotech companies. Practice co-lead Kiko Carrión regularly assists with SPC and copyright issues, in addition to handling invalidity actions and declarations of non-infringement. Co-head Marta González is recommended for her vast expertise in unfair competition, drawing on her prior in-house experience at global pharma companies. Fellow co-head Alberto Dorrego is singled out for his knowledge of public-private partnership (PPP) projects and public service concessions. Eduardo Buitrón handles a varied caseload of patent infringement actions and product liability claims.

Fieldfisher acts for a varied client roster of global pharma companies in a broad range of mandates concerning antitrust and regulatory issues. Practice head Héctor Jausàs is recommended for his deep knowledge of market access and advertising matters, and Gemma Colomer is an expert in compliance and contractual work within the pharma industry.

Noted for its strong transactional practice, Garrigues is a key contact for private equity, pharma, and medical device clients seeking assistance with M&A, merger control issues, and investment-focused matters. José Fernández-Rañada leads the team with his vast experience in handling corporate restructuring mandates and spin-offs. Javier Manchado is a key contact for public procurement issues, often handling work relating to public contract termination and performance, in addition to acting in judicial review appeals.

Hogan Lovells Spain assists a varied client list of global pharma, biotech, and medical device companies. Ana Castedo stands out for her expertise in medical device and medicinal patent infringement and validity proceedings, and jointly leads the team with Alex Dolmans, who focuses on corporate, M&A, and commercial mandates. Margarita Morales is a key name for global product liability claims and insurance litigation within the life sciences and healthcare spaces, areas in which Fátima Mallén has a great deal of expertise. Álvaro Abad is recommended for his broad knowledge of market access issues and promotional disputes.

Pérez-Llorca often handles complex regulatory issues concerning early access programmes, clinical trials, and market authorisations. Practice co-head Eduardo Castillo has longstanding experience in unfair competition and patent litigation, while fellow co-lead Juan Rodríguez Cárcamo stands out due to his vast knowledge of public procurement proceedings and disputes. Natalia Olmos is a key name for administrative issues relating to public procurement and asset liability claims. Rais Amils is no longer at the practice.

Paula González De Castejón and Diego Ramos jointly head the practice at DLA Piper, which regularly handles advertising work and distribution agreements. González de Castejón is recommended for her in-depth knowledge of pricing and reimbursement, clinical trial, and market access mandates, with a strong focus on transparency issues, while Ramos handles a broad caseload consisting of cybersecurity, marketing, and data protection work.

DWF-RCD is a key contact for public research institutes, pharma companies, and academic institutions. Ignasi Costas heads the practice, often handling corporate and M&A mandates, while Alejandro Griffiths advises on research collaboration contracts and consortium-related issues. Judith Saladrigas acts for a diverse client base of biotech companies, venture capital firms, and public administrations, and Oscar Alegre is a key contact for issues concerning R&D centres and tech transfers.

Noted for its strong focus on compliance models, Andersen is well equipped to handle GDPR implementation mandates, often assisting data protection officers within the pharma space. In addition to leading the firm’s privacy, IT & digital business team, Isabel Martínez Moriel utilises her longstanding experience to assist with the full gamut of data matters involving pharmacovigilance data and clinical trials.

CMS handles a broad range of issues concerning the advertising of medical devices, and both contentious and non-contentious IP matters. María González Gordon is adept at assisting medical device and pharma clients with IPR agreement negotiations. Ignacio Grangel is an expert in public law, and Mariano Bautista is noted for his deep knowledge of corporate restructuring issues and M&A.

Gómez-Acebo & Pombo is well-known for its strong corporate and M&A capabilities and its expertise in financing work. Practice head Irene Fernández Puyol often advises on regulatory issues concerning healthcare service requirements, the promotion of medicinal products, and public procurement issues. Jesús Muñoz Delgado is an IP expert with vast expertise in unfair competition, with a strong focus on biotech and plant variety matters. The team was strengthened by the addition of Rais Amils from Pérez-Llorca in January 2025.

HOYNG ROKH MONEGIER stands out for its distinctive focus on IP litigation within the pharma space, particularly in relation to patent enforcement and defence. Practice head Luis Fernández-Novoa draws on his vast experience in unfair competition issues and patent litigation within the life sciences space. Laura Cantero routinely acts for domestic and global clients in contentious IP mandates.

Marimón Abogados stands out for its strong focus on competition and EU law-related issues, including judicial reviews and the establishment of distribution systems. Yolanda Martínez is noted for her specialism in abuse of dominance and mandates concerning prohibitions to tender within the pharma industry. Diego Crespo is a key figure within the team who handles merger control and unfair competition work.

A popular choice for industry associations, Ramón y Cajal Abogados houses a practice known for its expertise in contentious public procurement work, in addition to advertising and pricing mandates. Jose Ignacio Vega co-leads the team alongside Norman Heckh. Vega is a key name for public law issues, often in relation to public procurement, while Heckh is recommended for his broad experience in data protection and IT agreements.